Published in Invest Ophthalmol Vis Sci on July 01, 1989
Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1990) 1.39
Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye. Int Ophthalmol (1998) 0.80
Ocular fluorophotometry. Br J Ophthalmol (1990) 0.77
Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM. Br J Ophthalmol (2001) 0.77
Transport of glucose from blood to brain. Physiol Rev (1979) 1.62
Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes. Diabetologia (2010) 1.41
Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1990) 1.39
Accurate superimposition of perimetry data onto fundus photographs. Acta Ophthalmol (Copenh) (1990) 1.29
The influence of stimulus size on perimetric detection of small scotomata. Graefes Arch Clin Exp Ophthalmol (1989) 1.21
Cotton-wool spots and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1991) 1.19
Potassium transport of the frog retinal pigment epithelium: autoregulation of potassium activity in the subretinal space. J Physiol (1986) 1.11
Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci (2001) 1.10
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med (2007) 1.06
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia (1989) 1.06
K+-permeability of the blood-brain barrier, investigated by aid of a K+-sensitive microelectrode. Acta Physiol Scand (1977) 1.04
Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh) (1994) 1.03
Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci (1985) 1.01
Effects of potassium content in brain-cortex slices from adult rats. Exp Brain Res (1970) 1.01
Photometric oculometry. I. An analysis of the optical principles in slit-lamp fluorophotometry. Acta Ophthalmol (Copenh) (1984) 0.98
Diabetic macular oedema: a clinical overview. Int J Clin Pract (2007) 0.97
Concordance between morphological and biochemical estimates of fluid spaces in rat brain cortex slices. Exp Brain Res (1974) 0.94
The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol (1998) 0.94
Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci (1999) 0.93
The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol (Copenh) (1981) 0.92
Extracellular and intracellular distribution of inulin in rat brain cortex slices. Brain Res (1974) 0.88
Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol (1991) 0.87
Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol (2002) 0.87
Lens autofluorescence is increased in newly diagnosed patients with NIDDM. Diabetologia (1996) 0.86
Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care (1998) 0.86
Lens fluorescence in relation to nephropathy in insulin-dependent diabetes mellitus. Graefes Arch Clin Exp Ophthalmol (1992) 0.85
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Acta Ophthalmol (Copenh) (1994) 0.85
Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo. Acta Ophthalmol (Copenh) (1994) 0.85
Detection of shallow detachments in central serous chorioretinopathy. Acta Ophthalmol Scand (1999) 0.84
Lens fluorescence in relation to metabolic control of insulin-dependent diabetes mellitus. Arch Ophthalmol (1989) 0.84
Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation. Acta Ophthalmol (Copenh) (1993) 0.83
Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Graefes Arch Clin Exp Ophthalmol (1991) 0.83
Lens fluorometry: light-attenuation effects and estimation of total lens transmittance. Graefes Arch Clin Exp Ophthalmol (1991) 0.82
Uptake of inulin by cells in rat brain cortex. Exp Brain Res (1977) 0.82
An improved holder for transfer of brain slices during in vitro incubation. Exp Brain Res (1970) 0.82
Lens autofluorescence in diabetes compared with the level of glycosylated hemoglobin A1c. Acta Ophthalmol Suppl (1987) 0.81
Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus. Acta Endocrinol (Copenh) (1990) 0.81
Uptake of glucose analogues by rat brain cortex slices: a kinetic analysis based upon a model. J Neurochem (1976) 0.81
Uptake of glucose analogues by rat brain cortex slices: membrane transport versus metabolism of 2-deoxy-D-glucose. J Neurochem (1977) 0.81
Absence of foveal avascular zone demonstrated by laser scanning fluorescein angiography. Acta Ophthalmol (Copenh) (1994) 0.80
Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye. Int Ophthalmol (1998) 0.80
Breakdown of the blood-retinal barrier in multiple sclerosis measured by vitreous fluorophotometry. Acta Ophthalmol (Copenh) (1986) 0.79
Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes. Diabetologia (2013) 0.78
Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients. Acta Ophthalmol (Copenh) (1987) 0.78
Photometric oculometry. II. Measurement of axial ocular distances with slit-lamp microscopy. Clinical evaluation, and comparison with ultrasonography. Acta Ophthalmol (Copenh) (1984) 0.77
Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Ophthalmol (1990) 0.77
Uptake of glucose analogues by rat brain cortex slices: Na+-independent membrane transport. J Neurochem (1976) 0.77
Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM. Br J Ophthalmol (2001) 0.77
The blood-retinal barrier permeability in essential hypertension. Acta Ophthalmol (Copenh) (1983) 0.77
Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier. Br J Ophthalmol (2002) 0.76
Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation. Br J Ophthalmol (1994) 0.75
The blood-retinal barrier permeability to fluorescein in normal subjects and in juvenile diabetics without retinopathy. Acta Ophthalmol (Copenh) (1986) 0.75
Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Graefes Arch Clin Exp Ophthalmol (1987) 0.75
Transient transport across the blood-retina barrier. Bull Math Biol (1983) 0.75
Near miss cot deaths and home monitoring. Br Med J (Clin Res Ed) (1983) 0.75
Fluorescein and fluorescein glucuronide in vitreous: fluorescence and binding properties in vitro. Acta Ophthalmol (Copenh) (1989) 0.75
Quantitative measurements of the fluorescence in limbal vessels by dynamic television angiography. Acta Ophthalmol (Copenh) (1979) 0.75
Photometric oculometry: a slit-lamp technique for determination of intraocular distances. Graefes Arch Clin Exp Ophthalmol (1985) 0.75
Fluorescein in human plasma in vitro. Acta Ophthalmol (Copenh) (1982) 0.75
The blood-retinal barrier permeability to fluorescein in juvenile diabetics treated with continuous subcutaneous insulin infusion. Acta Ophthalmol Suppl (1985) 0.75
K+ -permeability of the blood-brain barrier investigated by aid of a K+ -sensitive microelectrode [proceedings]. Arzneimittelforschung (1978) 0.75
Calculation of the permeability of the blood-retinal barrier to fluorescein. Graefes Arch Clin Exp Ophthalmol (1985) 0.75
[Chronic ergotism]. Ugeskr Laeger (1970) 0.75
Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein. Acta Ophthalmol (Copenh) (1988) 0.75
Senile macular degeneration. Results of laser treatment. A preliminary report. Acta Ophthalmol Suppl (1985) 0.75
Carriers of X-linked retinitis pigmentosa. A fluorophotometric determination of the permeability of the blood-retinal barrier. Ophthalmic Paediatr Genet (1986) 0.75
Blood-retina barrier permeability in diabetes during acute ACE-inhibition. Acta Ophthalmol (Copenh) (1991) 0.75
Determination of spatial coordinates in ocular fluorometry. Graefes Arch Clin Exp Ophthalmol (1991) 0.75
Transport of glucose across the blood-brain barrier: reevaluation of the accelerative exchange diffusion. Acta Physiol Scand (1982) 0.75
A comparative study of microvascular complications in patients with secondary and type 1 diabetes. Diabet Med (1990) 0.75
Fluorescein in human plasma in vivo. Acta Ophthalmol (Copenh) (1982) 0.75